Company Filing History:
Years Active: 2016
Title: Innovations in Myelin Regeneration by Said Ghandour
Introduction
Said Ghandour is an innovative inventor based in Strasbourg, France. He has made significant contributions to the field of neurodegeneration through his research and patents. His work focuses on methods for effective remyelination in patients, which is crucial for treating various neurological conditions.
Latest Patents
Said Ghandour holds a patent titled "Myelin regeneration with androgens." This patent discloses methods for effective remyelination in patients by treating them with an androgen receptor ligand. The ligand binds to androgen receptors and elicits biological responses at a dosage sufficient to induce remyelination. The preferred androgen compound in his patent is MENT, which targets both androgen and estrogen receptors. Additionally, the methods include combining the androgen compound with a progestin compound to provide contraception in men while also treating neurodegeneration.
Career Highlights
Said Ghandour is associated with The Population Council, Inc., where he continues to advance his research in the field of neurobiology. His work has the potential to impact the treatment of neurodegenerative diseases significantly.
Collaborations
Some of his notable coworkers include Regine Sitruk-Ware and Michael Maria Helmut Schumacher. Their collaboration enhances the research efforts in the field of myelin regeneration and neurodegeneration.
Conclusion
Said Ghandour's innovative approach to myelin regeneration through androgen receptor ligands represents a significant advancement in neurobiology. His contributions are paving the way for new treatments for neurodegenerative diseases.